Literature DB >> 12127544

N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus.

Edward Turos1, Timothy E Long, Monika I Konaklieva, Cristina Coates, Jeung Yeop Shim, Sonja Dickey, Daniel V Lim, Andrew Cannons.   

Abstract

In this report we describe a new family of N-thiolated beta-lactams that have antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). The compounds show unprecedented structure-activity features and an unusual mode of action for a beta-lactam antibiotic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127544     DOI: 10.1016/s0960-894x(02)00343-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  N-thiolated beta-lactams: Studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus.

Authors:  Kevin D Revell; Bart Heldreth; Timothy E Long; Seyoung Jang; Edward Turos
Journal:  Bioorg Med Chem       Date:  2006-12-20       Impact factor: 3.641

2.  The impact of fatty acids on the antibacterial properties of N-thiolated β-lactams.

Authors:  Katherine R Prosen; Ronan K Carroll; Whittney N Burda; Christina N Krute; Biplob Bhattacharya; My Lien Dao; Edward Turos; Lindsey N Shaw
Journal:  Bioorg Med Chem Lett       Date:  2011-07-19       Impact factor: 2.823

3.  Studies on the antifungal properties of N-thiolated beta-lactams.

Authors:  Marci O'Driscoll; Kerriann Greenhalgh; Ashley Young; Edward Turos; Sonja Dickey; Daniel V Lim
Journal:  Bioorg Med Chem       Date:  2008-06-25       Impact factor: 3.641

4.  Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis.

Authors:  Sampath C Abeylath; Edward Turos; Sonja Dickey; Daniel V Lim
Journal:  Bioorg Med Chem       Date:  2007-11-28       Impact factor: 3.641

5.  Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.

Authors:  Edward Turos; Kevin D Revell; Praveen Ramaraju; Danielle A Gergeres; Kerriann Greenhalgh; Ashley Young; Nalini Sathyanarayan; Sonja Dickey; Daniel Lim; Mamoun M Alhamadsheh; Kevin Reynolds
Journal:  Bioorg Med Chem       Date:  2008-05-17       Impact factor: 3.641

6.  Induction of tumor cell apoptosis by a novel class of N-thiolated beta-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring.

Authors:  Michael Frezza; Julio Garay; Di Chen; Cindy Cui; Edward Turos; Q Ping Dou
Journal:  Int J Mol Med       Date:  2008-06       Impact factor: 4.101

7.  Anti-tumor activity of N-thiolated beta-lactam antibiotics.

Authors:  Di Chen; Samuel C Falsetti; Michael Frezza; Vesna Milacic; Aslamuzzaman Kazi; Qiuzhi Cindy Cui; Timothy E Long; Edward Turos; Q Ping Dou
Journal:  Cancer Lett       Date:  2008-05-12       Impact factor: 8.679

8.  Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA.

Authors:  Edward Turos; G Suresh Kumar Reddy; Kerriann Greenhalgh; Praveen Ramaraju; Sampath C Abeylath; Seyoung Jang; Sonja Dickey; Daniel V Lim
Journal:  Bioorg Med Chem Lett       Date:  2007-03-27       Impact factor: 2.823

9.  Proline-based phosphoramidite reagents for the reductive ligation of S-nitrosothiols.

Authors:  Chung-Min Park; Tyler D Biggs; Ming Xian
Journal:  J Antibiot (Tokyo)       Date:  2016-01-13       Impact factor: 2.649

Review 10.  Molecular Targets of β-Lactam-Based Antimicrobials: Beyond the Usual Suspects.

Authors:  Monika I Konaklieva
Journal:  Antibiotics (Basel)       Date:  2014-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.